In 2021, Serena Viswanathan’s FTC team put more than 700 companies on notice: deceptive endorsements could cost up to $43,792 per violation.
FTC press release →
In 2023, Samuel Levine’s FTC warned 12 dietitians and influencers, and the trade groups that paid them, about unclear disclosures.
FTC warning letters →
In 2024, Lina Khan’s FTC made deceptive reviews and testimonials subject to civil penalties.
FTC press release →
In 2025, Allison Fitzpatrick, Paavana Kumar, Jordan Thompson and Amy Marcus flagged the rise of class actions over undisclosed paid endorsements.
Davis+Gilbert article →
In 2026, Marty Makary’s FDA warned 30 telehealth companies over their compounded GLP-1 marketing.
FDA press release →
In 2026, Raffael Heiss and colleagues found inconsistent disclosure across prescription-drug influencer promotion.
JAMA Network Open study →
In 2026, Business Insider found Matthew Gallagher’s Medvi selling through affiliate ads with apparent AI-generated doctors, some without clear disclosures.
Business Insider report →
